
Mazdutide
Dual GLP-1 and Glucagon Receptor Agonist Research
Ships Next Day
Order before midnight — dispatched tomorrow with cold-chain packaging
HPLC Verified
≥99.6% purity
Lyophilized
Powder format
Free Shipping
Cold-chain included
COA Included
Every batch
Verify Batch
Lot-level COA
Check required bloodwork before researching
View the Research Safety Companion — biomarkers, supplement stack & red flags for this compound
Mazdutide is a synthetic peptide engineered for its dual agonistic activity on both glucagon-like peptide-1 (GLP-1) and glucagon receptors. This compound is of interest in metabolic research for investigating receptor interaction and downstream signaling pathways.
Research Highlights
Reconstitution Calculator
Use bacteriostatic water for reconstitution. Store lyophilized at -20°C.
Quantity
Certificate of Analysis (COA)
Verified by Auxilium Pharmaceutical Consulting
Every batch is HPLC-tested to ≥99.6% purity. Certificate of Analysis and MSDS available with every order.
Frequently Asked Questions
What is Mazdutide?
Mazdutide is a synthetic peptide engineered for its dual agonistic activity on both glucagon-like peptide-1 (GLP-1) and glucagon receptors. This compound is of interest in metabolic research for investigating receptor interaction and downstream signaling pathways.
What purity is Mazdutide supplied at?
Pure Peptides supplies Mazdutide at ≥99.6% (HPLC) purity, verified by HPLC analysis. A Certificate of Analysis (COA) is available for every batch.
How should Mazdutide be stored?
Store lyophilized peptide at -20°C. After reconstitution, store at 4°C for short-term use or -20°C for long-term storage.
Does Mazdutide come with a Certificate of Analysis?
Yes. Every batch of Mazdutide from Pure Peptides includes a Certificate of Analysis (COA) confirming identity, purity, and quality. MSDS documentation is also available upon request.
Related Compounds — Metabolic Peptides
Verified Reviews
What Researchers Say
No reviews yet
Be the first to share your research experience with Mazdutide

Semaglutide: GLP-1 Receptor Agonist Research Overview
Semaglutide is a GLP-1 receptor agonist with a fatty acid modification enabling albumin binding and a plasma half-life of approximately one week. It has been extensively studied in metabolic disease models and has become a key research tool for understanding the GLP-1 axis.

Tirzepatide: Dual GIP/GLP-1 Receptor Agonist Research Review
Tirzepatide is a novel dual agonist targeting both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. Its dual mechanism has produced some of the most significant metabolic effects observed in incretin-based research.

Retatrutide (Reta Peptide): The Triple Agonist Rewriting Metabolic Research
Retatrutide — searched as 'reta peptide' — is a synthetic triple agonist targeting GLP-1R, GIPR, and GCGR simultaneously. Phase 2 data showed ~24% projected weight reduction at 48 weeks, surpassing all predecessor GLP-1 compounds.

Mazdutide
Mazdutide
$299.00




